Rat sponge implant model: a new system for evaluating angiogenic gene transfer

Area of Science:

• Cardiovascular Research
• Gene Therapy
• Vascular Biology

Background:

• Therapeutic angiogenesis shows promise for treating coronary and peripheral artery diseases.
• Comparing the efficacy of various angiogenic genes requires a standardized system.
• Adenovirus vectors offer a method for gene delivery in therapeutic angiogenesis.

Purpose of the Study:

• To establish a standardized adenovirus-mediated gene delivery system for comparing angiogenic gene efficacy.
• To evaluate the angiogenic potential of human VEGF121 delivered via adenovirus vector in a rat sponge implant model.
• To determine the dose-response relationship of adenovirus-mediated VEGF121 gene therapy on angiogenesis.

Main Methods:

• Utilized a replication-deficient adenovirus vector to deliver beta-galactosidase (reporter gene) or human VEGF121 gene.
• Employed a rat sponge implant model to assess gene transfection efficiency and angiogenesis.
• Quantified VEGF protein expression and measured angiogenesis by capillary number and tissue ingrowth.

Main Results:

• Achieved high transfection efficiency (up to 60%) with AdLacZ.
• Demonstrated significant VEGF121 protein expression (>10,000 pg/mg) within 24 hours, with detectable levels for 14 days.
• Observed a 2- to 3-fold increase in angiogenesis (capillary number, tissue ingrowth) with AdGVVEGF121.10 compared to controls.
• Confirmed a dose-related angiogenic response to AdGVVEGF121.10.

Conclusions:

• Adenovirus-mediated delivery of VEGF121 is an effective strategy for inducing therapeutic angiogenesis.
• The rat sponge implant model provides a reliable system for evaluating angiogenic gene therapy efficacy.
• The study highlights a dose-dependent relationship between VEGF121 gene therapy and enhanced angiogenesis.